Newstral
Article
post-gazette.com on 2016-10-03 21:00
House panel: Mylan CEO minimized EpiPen profits in testimony
Related news
- Updated: House panel: Mylan CEO minimized EpiPen profits in testimonyabqjournal.com
- Mylan: Epipen profits higher than Bresch told Congresstriblive.com
- Mylan profits, reputation at stake in EpiPen controversytriblive.com
- Mylan CEO set to defend EpiPen prices amid public outcrynewsobserver.com
- Mylan paying a price for its EpiPen richesobserver-reporter.com
- Mylan CEO to testify in hearing on EpiPen price increasesdothaneagle.com
- Mylan to pay $465 million settlement over Medicaid EpiPen rebatesChicago Tribune
- Mylan to pay $465M settlement over Medicaid EpiPen rebateskansascity.com
- Mylan to Pay $465M Settlement Over Medicaid EpiPen Rebatesmemphisdailynews.com
- MMylan CEO to answer for EpiPen price hikemoney.cnn.com
- Mylan CEO defends EpiPen pricesKHQ Local News
- Mylan investors push back over EpiPen maker’s executive salariesSan Jose Mercury News
- Funds looking to oust Mylan directors over Epipen uproarNew York Post
- Mylan investors raise a fuss over EpiPen maker’s executive salariesSan Jose Mercury News
- Last shot at EpiPen profits ends in Mylan monopolyThe Daily Gazette
- Mylan CEO: EpiPen $608 Price Was 'Fair'wsj.com
- Mylan launching generic version of EpiPenwaff.com
- Mylan launching cheaper, generic version of EpiPennwaonline.com
- EpiPen maker Mylan to restructure, cut workforcetriblive.com